Emblem Corp (OTCMKTS:EMMBF) reported that the firm has successfully increased its patient acquisition plan driving in around 2,090 active and pending patients having enrolled since the start of its patient fulfillment site in last November.
Patient acquisition has been accelerating with 49 subjects registered in last November, 157 in December 2016, and around 1680 in the first quarter of this year with a further 246 enrollments pending verification.
Gordon Fox, the CEO of Emblem, reported that they are extremely delighted with the progress recorded since the launch of website to attract and enroll patients at an accelerated rate. They consider that the patient acquisition growth is a promising reflection on the quality of company’s cannabis products, the customer service and the doctor and patient communication strategies.
Emblem also reported that its vertical unit GrowWise Health is expanding its clinic network. GrowWise clinics and cannabis knowledge centers promise to become a vital source of patients for company. With more and more physicians embracing cannabis as one of the treatment alternatives and getting comfortable referring it to patients, GrowWise is expanding its operations across Canada.
The company has already commenced four new GrowWise locations in Canada for people across Ontario and in British Columbia. This brings the total count of clinics in Canada to 11, with more sites intended to launch across the country in the coming period.
In March, Emblem retained Nate Nienhuis consulting services for its Canadian cannabis operations. It marks an important milestone for the company as Mr. Nienhuis is a known name throughout North America. He is a pre-eminent expert in the field of cannabis horticulture as well as cannabis extraction.
Nienhuis, an engineer, has consulted extensively on lighting systems building envelope design and environmental systems, for closed-box cannabis manufacturing facilities. He has the skills that company needs to design and manage the facilities that will meet Emblem’s mandate of producing the top quality cannabis offerings for the Canadian market.
Enter The $100 Cannabis Markethttp://www.financialstrend.com
VBIO cannabis industry setup for explosive growth
Top Stock Analysis At Journal Transcripthttp://www.journaltranscript.com
Early bird alerts on the hottest OTC companies
2017 Most Disruptive Biotech VBIOhttp://www.financialstrend.com
Disruptive biotech VBIO decodes targeted drug delivery for stem cells
Can CBD Oil Get Rid of Chronic Pain?http://www.greenleaf.farm
Pure Colorado Golden CBD Oil Hemp Extracts
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of journaltranscript.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure